Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Open Label, One-arm, 4-weeks Study Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease Phase 1 Study in Dry Eye Patients

Trial Profile

A Prospective, Open Label, One-arm, 4-weeks Study Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease Phase 1 Study in Dry Eye Patients

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2018

At a glance

  • Drugs Diquafosol (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Santen Pharmaceutical
  • Most Recent Events

    • 30 Aug 2018 Status changed from recruiting to completed.
    • 18 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 18 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top